摘要:
A roller assembly for a sliding door that slides along a track includes an anti-jump member engageable with the track to prevent the roller assembly from derailing. The roller assembly comprises a bracket adapted for attachment to the door, a roller mounting member slidably seated in the bracket, and a roller rotatably mounted on the roller mounting member for travel along the track. The anti-jump member is pivotably supported in and displaceably carried by the roller mounting member for movement between an extended operative position wherein an engagement portion on the lower end thereof rides in the track, and a retracted inoperative position, wherein the engagement portion is spaced upwardly from the track. The roller assembly is operable to slide the door with the anti-jump member in either the operative position or the retracted position.
摘要:
The present invention provides isolated and purified polynucleotides and polypeptides related to the IL-17F signaling pathway. The invention also provides antibodies to IL-17F homodimers and IL-17A/IL-17F heterodimers, and methods of isolating and purifying members of the IL-17 family, including IL-17A/IL-17F heterodimers, from a natural source. The present invention also is directed to novel methods for diagnosing, prognosing, monitoring the progress of, and treating and/or preventing disorders related to IL-17F signaling, i.e., IL-17F-associated disorders, including, but not limited to, inflammatory disorders, such as autoimmune diseases (e.g., arthritis (including rheumatoid arthritis), psoriasis, systemic lupus erythematosus, and multiple sclerosis), respiratory diseases (e.g., COPD, cystic fibrosis, asthma, allergy), transplant rejection (including solid organ transplant rejection), and inflammatory bowel diseases or disorders (IBDs, e.g., ulcerative colitis, Crohn's disease). The present invention is further directed to novel therapeutics and therapeutic targets, and to methods of screening and assessing test compounds for the intervention (treatment) and prevention of disorders related to IL-17F signaling.
摘要:
Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
摘要:
Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
摘要:
This invention directs to a video/motion picture displaying apparatus for viewing via 3D spectacles with an internal 3D synchronizing unit including an image capturing means, a synchronizing means to identify synchronization events according to a set of synchronization rules, and a transmitting unit. It further directs to a 2D video/motion picture embedded with synchronizing signals produced with the same synchronization rules. The invention also discloses a 3D synchronizing signal composing/embedding device for embedding synchronizing signals to a 2D video/motion picture including a data capturing means, a converting means, a synchronizing means and a composing means or an embedding means. It also teaches a related 3D control device configured to acquire and utilize the embedded synchronizing signals to control the transmission of light of the 3D spectacles.
摘要:
This invention discloses a 3-D Phenomenoscope through which any 2-dimensional motion picture with passages of horizontal screen movement can be viewed with a 3-dimensional visual effect. The 3-dimensional visual effect is produced by the 3-D Phenomenoscope regardless of whether the motion picture was shot on regular or digital film; regardless of whether the presentation media is film, digital film, VCR tape, or DVD, and; regardless of whether the motion picture is viewed in the movie theater, home TV, Cable TV, or on a PC monitor. No special processing during production or showing of a motion picture is required to achieve the visual effect of the 3-D Phenomenoscope—so no new constraints are placed on the owner, producer, distributor, or projectionist in creating, distributing or displaying motion pictures. The 3-D Phenomenoscope are completely self-contained computer-actuated battery-powered spectacles or glasses that a viewer wears when watching a motion picture. When the 3-D Phenomenoscope glasses are activated the viewer will see lateral motion in a motion picture in 3-dimensions. When the 3-D Phenomenoscope is not activated or the glasses are turned off, or if the viewer is not wearing the 3-D Phenomenoscope glasses, then the viewer will see the motion picture unchanged and without any special effects. The preferred embodiment of the invention presents a method and system for a 3-D Phenomenoscope to view 3-dimensional special effects in motion pictures, and disclose a system by which ordinary 2-dimensional motion pictures can be viewed as a 3-dimensionsal experience. The 3-D Phenomenoscope achieves this by taking advantage of the well-known Pulfrich effect, by which passages of lateral motion of an ordinary motion picture will appear to the viewer in 3-Dimensions if the motion picture is viewed through right and left lenses that are configured with a clear lens and a light-reducing or darker lens. Ordinary eyeglasses are configured with: (a) Right and left lenses for which the degree of clarity or darkening of the lens can be individually controlled (b) Digital photo sensors (a digital camera) that can capture the viewed motion picture as successive images and convert the captured frames to digital images for processing (c) Computer processor to process the successive images and identify lateral motion synchronization events, and (d) Ability to provide individual control for the light-reduction or darkening of the right or left lens based on the identified synchronization events. In this way, the 3-D Phenomenoscope provides a fully self-contained apparatus that allow any motion picture to be viewed with the visual effect of 3-dimensions.
摘要:
Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.